The Anti-aging Therapeutics Market Size is valued at 692.66 Million in 2023 and is predicted to reach 2,527.33 Million by the year 2031 at a 17.62% CAGR during the forecast period for 2024-2031.
Anti-aging treatment combines cutting-edge research and medical technology to identify, prevent, cure, and reverse age-related dysfunctions, illnesses, and diseases as early as possible. As a result, anti-aging preventive medicine and healthcare are critical components in assisting senior people in living healthy and active lives. The progress of technology offers the detection, prevention, and treatment of age-related diseases and the promotion of research into strategies to slow and optimize the human ageing process. Researchers have made considerable progress in understanding stem cell ageing and the molecular processes behind this process during the last decade. Few studies have also validated the extrinsic factors, while transplantation experiments have found the intrinsic components that induce an age-dependent reduction in stem cell quantity and function.
The rise in consumer demand for anti-aging therapeutics, combined with an increase in lifestyle standards and income among the world's population, is the primary factor driving the growth of the anti-aging therapeutics market over the forecast period. Furthermore, technological advancements and increased investment in research and development activities by major players for the development of highly safe and efficient treatment solutions are expected to propel the anti-aging therapeutics market globally.
The Anti-aging Therapeutics market is segmented on the basis of type of molecule, type of aging and mechanism of action. Based on type of molecule, the market is segmented as Biologics and Small Molecules. The type of aging segment includes Cellular Aging, Immune Aging, Metabolic Aging and Others. By mechanism of action, the market is segmented into Senolytic, Cell Regeneration, mTOR inhibitor/Modulator, AMP-kinase/AMP Activator, Mitochondria Inhibitor/Modulator and Others.
The small molecule segment is accounted as a major contributor in the Anti-aging Therapeutics market. Small molecules can delay multiple aging diseases and increase lifespan. In theory, such molecules could simultaneously prevent dozens of diseases, potentially extending healthy years of life.
Cellular aging is generally defined as a progressive decrease in resistance to stress and other cellular damages, resulting in a gradual loss of cellular functions and, eventually, cell demise. Cells age as they divide, multiply, and perform their assigned functions. And as they age, the body has remarkable mechanisms in place to care for aging cells and replenish them with new ones.
The anti-aging therapeutics market in North America is expected to grow significantly due to the availability of well-established infrastructure, key market players, and the region's increasing average life expectancy and median age. However, the rising popularity of anti-aging therapeutics and favorable reimbursement policies are expected to boost regional growth during the forecast period. Furthermore, companies in the region are working hard to improve their market position through R&D and new product launches. Moreover, Asia Pacific is the most populous region on the planet, with a sizable market for anti-aging therapeutics. The development of infrastructure and facilities to advance stem cell research in both developed and emerging nations is driving market expansion in this region.
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 692.66 Million |
|
Revenue forecast in 2031 |
USD 2,527.33 Million |
|
Growth rate CAGR |
CAGR of 17.62% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
Type of Molecule, Type of Aging, Mechanism of Action |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
AgelessRx, ANOVA Institute for Regenerative Medicine, Betterhumans, BioAge Labs, BIOPHYTIS BSA, bioXcellerator, Cambrian Biopharma, CytoMed Therapeutics, Gero.ai, Rejuvenate Bio, Rejenevie Therapeutics, MyMD Pharmaceuticals, Intervene Immune, Inc., CohBar, Inc., Alkahest, Athersys Inc, BHB Therapeutics, Biosplice, Cyclo Therapeutics, Denali Therapeutics, Elysium Health, Genome Protection, GenSight Biologics, Intervene Immune, Khondrian, Longeveron, LyGenesis, Mesoblast, Minovia Therapeutics, Mitobridge, Navitor Pharmaceuticals, NeuroTrack, Nuchido, NuSirt, OneSkin Technologies, PharmatrophiX, Proteostasis Therapeutics, Retrotope, Stealth Biotherapeutics, TA Sciences, Unity BiotechnologyYounger Phenotype, and Other Prominent Players. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Anti-aging Therapeutics Market Snapshot
Chapter 4. Global Anti-aging Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Molecule, Estimates & Trend Analysis
5.1. By Molecules, & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Molecules:
5.2.1. Biologics
5.2.2. Small Molecules
Chapter 6. Market Segmentation 2: By Aging Types Estimates & Trend Analysis
6.1. By Aging Types & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Aging Types:
6.2.1. Cellular Aging
6.2.2. Immune Aging
6.2.3. Metabolic Aging
6.2.4. Other Aging Types
Chapter 7. Market Segmentation 3: By Mechanism of Action Estimates & Trend Analysis
7.1. By Mechanism of Action & Market Share, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Mechanism of Action:
7.2.1. Senolytic
7.2.2. Cell Regeneration
7.2.3. mTOR inhibitor/Modulator
7.2.4. AMP-kinase/AMP Activator
7.2.5. Mitochondria Inhibitor/Modulator
7.2.6. other Mechanism of Action
Chapter 8. Anti-aging Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Molecules, 2024-2031
8.1.2. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Aging Types, 2024-2031
8.1.3. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Mechanism of Action, 2024-2031
8.1.4. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2024-2031
8.2.2. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2024-2031
8.2.3. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2024-2031
8.2.4. Europe Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2024-2031
8.3.2. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2024-2031
8.3.3. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2024-2031
8.3.4. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2024-2031
8.4.2. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2024-2031
8.4.3. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2024-2031
8.4.4. Latin America Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2024-2031
8.5.3. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2024-2031
8.5.4. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AgelessRx
9.2.2. ANOVA Institute for Regenerative Medicine
9.2.3. Betterhumans
9.2.4. BioAge Labs
9.2.5. BIOPHYTIS BSA
9.2.6. bioXcellerator
9.2.7. Cambrian Biopharma
9.2.8. CytoMed Therapeutics
9.2.9. Gero.ai
9.2.10. Rejuvenate Bio
9.2.11. Rejenevie Therapeutics
9.2.12. UT Health San Antonio
9.2.13. MyMD Pharmaceuticals
9.2.14. Intervene Immune, Inc.
9.2.15. CohBar, Inc.
9.2.16. Alkahest
9.2.17. Athersys Inc
9.2.18. BHB Therapeutics
9.2.19. Biosplice
9.2.20. Cyclo Therapeutics
9.2.21. Denali Therapeutics
9.2.22. Elysium Health
9.2.23. Genome Protection
9.2.24. GenSight Biologics
9.2.25. Intervene Immune
9.2.26. Khondrian
9.2.27. Longeveron
9.2.28. LyGenesis
9.2.29. Mesoblast
9.2.30. Minovia Therapeutics
9.2.31. Mitobridge
9.2.32. Navitor Pharmaceuticals
9.2.33. NeuroTrack
9.2.34. Nuchido
9.2.35. NuSirt
9.2.36. OneSkin Technologies
9.2.37. PharmatrophiX
9.2.38. Proteostasis Therapeutics
9.2.39. Retrotope
9.2.40. Stealth Biotherapeutics
9.2.41. TA Sciences
9.2.42. Unity Biotechnology
9.2.43. Younger Phenotype
9.2.44. Other Prominent Players
By Type of Molecule
By Type of Aging
By Mechanism of Action
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
